THE ROLE OF CORTICOSTEROIDS IN COPD
Abour Author: Kesinath Kotha*1, Varun Raj Vemula2, Rupesh Kotte3
1. Department of Pharmacy Practice, St Peters institute of pharmaceutical sciences, Warangal, A.P
2. Department of Pharmaceutical Chemistry, Vikas College of Pharmacy, Warangal, A.P.
3. SRR college of pharmaceutical sciences, Karimnagar, A.P.
ABSTRACT
Chronic obstructive pulmonary disease (COPD) is chronic obstruction of the flow of air through the airways and out of the lungs, and the obstruction generally is permanent and may be progressive over time. According to WHO in India, a study collecting data without spirometry assessment suggested that 12 million people were affected by chronic obstructive pulmonary disease. Recent studies show a prevalence of respiratory symptoms in 6%–7% of non-smokers and up to 14% of smokers. In a recent study in southern India, the prevalence rate of COPD in adults was around 7%. COPD is the fourth leading cause of death in the U.S. and the economic burden of COPD in the U.S. in 2007 was $42.6 billion in health care costs and lost productivity.
In view of its importance, the use of corticosteroids in treatment & management of COPD in acute & chronic conditions has been discussed along with emphasis on recent research trends. Use of corticosteroids & different combination products in the treatment of COPD along with their uses and side effects are presented.